The implement of intraabdominal pathophysiology on the treatment of abdominal sepsis;Klinische bedeutung der intraabdominalen pathophysiologie fur die peritonitisbehandlung

Zentralblatt fur Chirurgie

Volumn 123, Issue SUPPL. 3, 1998, Pages 14-17

  Billing, A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Abdominal lavage; Abdominal sepsis; Pathophysiology; Therapy

Indexed keywords

ABSCESS; ABSCESS DRAINAGE; FIBRIN DEPOSITION; HUMORAL IMMUNITY; LAPAROTOMY; LAVAGE; PERITONEAL CAVITY; PERITONITIS; RECURRENT INFECTION; REVIEW; SEPSIS; TREATMENT OUTCOME;

EID: 0031843135     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Akalin HE, Laleli Y, Telatar H (1983) Bactericidal and opsonic activity of ascitic fluid from cirrhotic and noncirrhotic patients. J Infect Dis 147: 1011-1017
2. Almdahl SM, Bogwald J, Hoffmann J, Giercksky K-E, Seijelid R (1978) Protection by aminated glucan in experimental endogenous peritonitis. Eur Surg Res 19: 78-85
3. Billing A, Frohlich D, Konecny G, Schildberg FW, Machleidt W, Fritz H, Jochum M (1994) Local serum application: restoration of sufficient host defense in human peritonitis. Eur J Clin Invest 24: 28-35
4. Billing A, Jochum M, Frohlich D, Cheronis JC, Fritz H (1997) Oxidative autoaggression by phagocytes in human peritonitis. Eur J Clin Invest 27: 1030-1037
5. Chalkiadakias G, Kostakis A, Karayannacos PE (1983) The effect of heparin upon fibrinopurulent peritonitis in rats. Lab Invest 48: 479-491
6. Chong KT (1987) Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria. Infect Immu 55: 668-673
7. Christou NV (1990) Systemic and peritoneal host defense in peritonitis. World J Surg 14: 184-190
8. Conn HO, Fessel JM (1971) Spontaneous bacterial peritonitis in cirrhosis: Variations on a theme. Medicine 50: 161-197
9. Dakin HD (1916) The behaviour of hypochlorites on intravenous injection and their action on blood serum Br Med J 1: 852-854
10. Dunn DL, Barke RA, Ahrenholz DH, Humphrey EW, Simmons RL (1984) The adjuvant effect of peritoneal fluid in experimental peritonitis. Ann Surg 19911: 37-43
11. Duswald KH (1982) Zur Pathobiochemie der Leukozyten-Elastase und ausgewahlter Plasma-Proteine bei Sepsis nach abdominalchirurgischen Eingriffen. Habilitationsschrift LMU Munchen
12. Edmiston CE, Goheen MP, Kornhall S, Jones FE, Condon RE (1990) Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage. World J Surg 14: 176-183
13. Emerson T (1987) Effects of purified fibronectin alone and combined with immunoglobulin G or antithrombin-III on survival during gram-negative peritonitis or endotoxemia in rats. J Trauma 27: 1261-1266
14. Hau T (1990) Bacteria, toxins, and the peritoneum. World J Surg 14: 167-175
15. Hau T, Simmons RL (1978): Heparin in the treatment of experimental peritonitis in rats. Ann Surg 187: 294-298
16. Howe HJ, Casali RE, Westbrook KC, Thompson BW, Read RC (1979) Acute perforations of the sigmoid colon secondary to diverticulitis. Am J Surg 137: 184-187
17. Inoue S (1990) Therapeutic implications of plasma C3 rich fraction against bacterial infection in surgical patients. Nippon Geka Gakkai Zasshi 90/7: 988-998
18. Jochum M, Inthorn D, Nast-Kolb D, Fritz H (1991) AT III - ein neues therapeutisches Konzept bei der Behandlung der Sepsis und beim Organversagen? In: Henschel WF (Hrsg) Blut, Blutkomponenten und Blutersatzstoffe in der Intensivmedizin. Bericht über das 10. Bremer Interdisziplinäre Intensivtherapie-Colloquium. S. 46-58. München: Zuckschwerdt
19. Joyce LD, Hau T, Huffman R (1978) Evaluation of the mechanism of zyrnosan-induced resistance to experimental peritonitis. Surgery 83: 717-725
20. Levy R, Kain Z, Chaimovitz C, Frifkin M, Segal S, Alkan M (1989) Potential use of tuftsin in treatment of Candida peritonitis in a murine model. J Biol Regul Homeost Agents 3/2, 71-78
21. Maddaus MA, Ahrenholz D, Simmons RL (1988) The biology of peritonitis and implications for treatment. Surg Clin North Am 68: 431-443
22. Penninckx FM, Kerremanns RP, Lauwers PM (1983) Planned relaparotomies in the surgical treatment of severe generalized peritonitis from intestinal origin. World J Surg 7: 762-766
23. Polk HC, Fry DE(1980) Radical peritoneal debridement for established peritonitis. Ann Surg 192: 350-355
24. Rankin JA, Sylvester I, Smith S, Yoshimura T, Leonard J (1990) Macrophages cultured in vitro release leuktriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and Zymosan A. J Clin Invest 86: 1556-1564
25. Rosman C, Westerveld GJ, Oeveren W, Kooi K, Bleichrodt RP (1996) Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats. Eur Surg Res 28: 351-360
26. Rotstein OD, Kao J (1988) Prevention of intra-abdominal abscesses by fibrionlysis using recombinant tissue plasminogen activator. J Infect Dis 15814: 766-772
27. Rotstein OD, Pruett TL, Simmons RL (1985) Microbiologic features and treatment of persistent peritonitis in patients in the intensive care unit. Can J Surg 29: 247-250
28. Saba TM, Blumenstock FA, Shah D (1986) Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Am J Med 80: 398-414
29. Schein M, Saadia R, Decker G (1988) Intraoperative peritoneal lavage. Surg Gynecol Obstet 166: 187-195
30. Siebeck M, Hoffmann H, Jochum M, Fritz H (1989) Inhibition of proteinases with recombinant Eglin C during experimental E. coli septicemia in the pig. Eur Surg Res 21: 11-17
31. Strieter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, Baggiolini M, Kunkel SL (1990) Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-α, lipopolysaccharide, and interleukin-1 β. Am J Respir Cell Mol Biol 2: 321-326
32. Travis J, Fritz H (1991) Potential problems in designing elastase inhibitors for therapy. Am Rev Respir Dis 143: 1412-1415
33. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365-376